Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-31falsetrue0truetruetruetrue2024-04-010falsefalse 09214706 2024-04-01 2025-03-31 09214706 2023-04-01 2024-03-31 09214706 2025-03-31 09214706 2024-03-31 09214706 2023-04-01 09214706 c:Director1 2024-04-01 2025-03-31 09214706 c:Director2 2024-04-01 2025-03-31 09214706 c:Director4 2024-04-01 2025-03-31 09214706 c:Director5 2024-04-01 2025-03-31 09214706 c:RegisteredOffice 2024-04-01 2025-03-31 09214706 d:CurrentFinancialInstruments 2025-03-31 09214706 d:CurrentFinancialInstruments 2024-03-31 09214706 d:Non-currentFinancialInstruments 2025-03-31 09214706 d:Non-currentFinancialInstruments 2024-03-31 09214706 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 09214706 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 09214706 d:Non-currentFinancialInstruments d:AfterOneYear 2025-03-31 09214706 d:Non-currentFinancialInstruments d:AfterOneYear 2024-03-31 09214706 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2025-03-31 09214706 d:Non-currentFinancialInstruments d:BetweenOneTwoYears 2024-03-31 09214706 d:UKTax 2024-04-01 2025-03-31 09214706 d:UKTax 2023-04-01 2024-03-31 09214706 d:ShareCapital 2025-03-31 09214706 d:ShareCapital 2024-03-31 09214706 d:ShareCapital 2023-04-01 09214706 d:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 09214706 d:RetainedEarningsAccumulatedLosses 2025-03-31 09214706 d:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 09214706 d:RetainedEarningsAccumulatedLosses 2024-03-31 09214706 d:RetainedEarningsAccumulatedLosses 2023-04-01 09214706 d:TaxLossesCarry-forwardsDeferredTax 2025-03-31 09214706 d:TaxLossesCarry-forwardsDeferredTax 2024-03-31 09214706 c:OrdinaryShareClass1 2024-04-01 2025-03-31 09214706 c:OrdinaryShareClass1 2025-03-31 09214706 c:OrdinaryShareClass1 2024-03-31 09214706 c:FRS102 2024-04-01 2025-03-31 09214706 c:Audited 2024-04-01 2025-03-31 09214706 c:FullAccounts 2024-04-01 2025-03-31 09214706 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09214706 d:Subsidiary1 2024-04-01 2025-03-31 09214706 d:Subsidiary1 1 2024-04-01 2025-03-31 09214706 d:Subsidiary2 2024-04-01 2025-03-31 09214706 d:Subsidiary2 1 2024-04-01 2025-03-31 09214706 6 2024-04-01 2025-03-31 09214706 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure

Registered number: 09214706









AVERY CARE (CANNOCK) LIMITED









ANNUAL REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2025

 
AVERY CARE (CANNOCK) LIMITED
 
 
COMPANY INFORMATION


Directors
J M B Strowbridge 
C L C Colt 
S B Olsson 
D A Reuben 




Registered number
09214706



Registered office
3 Cygnet Drive
Swan Valley

Northampton

NN4 9BS




Independent auditor
Adler Shine LLP
Chartered Accountants & Statutory Auditor

Aston House

Cornwall Avenue

London

N3 1LF





 
AVERY CARE (CANNOCK) LIMITED
 

CONTENTS



Page
Strategic Report
 
1 - 2
Directors' Report
 
3 - 4
Independent Auditors' Report
 
5 - 8
Statement of Comprehensive Income
 
9
Balance Sheet
 
10
Statement of Changes in Equity
 
11
Notes to the Financial Statements
 
12 - 22


 
AVERY CARE (CANNOCK) LIMITED
 
 
STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025

Introduction
 
The directors present their Strategic Report for the year ended 31 March 2025.

Business review
 
The Company acts as an interim holding company. Subsidiaries are operated as residential care for the elderly and disabled during the year.
Due to the limited activity within the Company, a detailed business review for the group, including an analysis of principle risks and uncertainties, review of key performance indicators and engagement with employees and suppliers can be found in the Strategic Report of Avery Healthcare Holdings Limited, a group company registered in England and Wales.

Principal risks and uncertainties
 
The Company is part of the Avery Healthcare Group. The principal risks faced by the Company reflect those of the Avery Healthcare Group in delivering its strategic priorities for the forthcoming year. These are listed below:
•  Continued assessment of the long term care sector and the potential changes on the horizon;
•  Review of government policy and the impact on the care sector of proposed changes in either social 
 economic terms or direct government focus. Respond to potential changes in the general political view of 
 the privately provided care sector;
•  Review of the housing market and pensions, enabling an assessment of service user’s ability to pay for 
 care services; and
•  Managing the financial risk resulting from fluctuations in interest rates through appropriate hedging 
 arrangements.
Objectives
•  To establish and integrate care homes within the Avery Healthcare Holdings group. They will all be of the
 highest quality from both an environmental and care delivery perspective;
•  To recruit and provide training to staff of a similarly high calibre;
•  Continue to evolve and use our quality assurance system to assist in this aim of providing high quality    care
 to the vulnerable elderly;
•  Continuous expenditure on the environment and fabric of the buildings. Continued recognition of the 
 importance of this to the residents of our facilities;
•  To achieve above industry average outcomes from reviews and inspections undertaken by sector 
 regulators; and
•  To achieve a financial performance in line with budget and in excess of sector norms.
How we will achieve this
•  Providing a career path for all our staff;
•  Providing the training and support to teach staff the art of caring;
•  Complying with all regulatory requirements; and
•  Providing better care than our competitors.
How we will assess our performance
•  Close supervision of home managers by high calibre and experienced regional managers;
•  Achievable care home budgets; and
•  Weekly reporting to care home managers on key performance indicators.

Page 1

 
AVERY CARE (CANNOCK) LIMITED
 

STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025

Financial key performance indicators
 
The Company monitors the performance of the business using the following:
•  Earnings before interest, depreciation, amortisation and tax; and
•  Operating cash generation.

Other key performance indicators
 
Management monitor and review financial and non-financial KPIs such as: occupancy rates, average fee rates, agency usage and its Care Quality Commission ratings.


This report was approved by the board and signed on its behalf.



................................................
S B Olsson
Director

Date: 19 December 2025

Page 2

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2025

The directors present their report and the financial statements for the year ended 31 March 2025.

Directors' responsibilities statement

The directors are responsible for preparing the Strategic Report, the Directors' Report and the financial statements in accordance with applicable law and regulations.
 
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Company and of the profit or loss of the Company for that period.

 In preparing these financial statements, the directors are required to:


select suitable accounting policies for the Company's financial statements and then apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable them to ensure that the financial statements comply with the Companies Act 2006They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Principal activity

The principal activity of the Company is that of an interim holding company

Results and dividends

The loss for the year, after taxation, amounted to £254,611 (2024 - profit £617,261).

Directors

The directors who served during the year were:

J M B Strowbridge 
C L C Colt 
S B Olsson 
D A Reuben 

Future developments

The Company continues to drive the same standards and service levels while seeking to continue to grow the business and its offering.

Page 3

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025

Disclosure of information to auditors

Each of the persons who are directors at the time when this Directors' Report is approved has confirmed that:
 
so far as the director is aware, there is no relevant audit information of which the Company's auditors are unaware, and

the director has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company's auditors are aware of that information.

Post balance sheet events

There have been no significant events affecting the Company since the year end.

Auditors

The auditorsAdler Shine LLPwill be proposed for reappointment in accordance with section 485 of the Companies Act 2006.

This report was approved by the board and signed on its behalf.
 



................................................
S B Olsson
Director

Date: 19 December 2025

Page 4

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF AVERY CARE (CANNOCK) LIMITED
 

Opinion


We have audited the financial statements of Avery Care (Cannock) Limited (the 'Company') for the year ended 31 March 2025, which comprise the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes, including a summary of significant accounting policiesThe financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).


In our opinion the financial statements:


give a true and fair view of the state of the Company's affairs as at 31 March 2025 and of its loss for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.


Basis for opinion


We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.


Conclusions relating to going concern


In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.


Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.


Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.


Page 5

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF AVERY CARE (CANNOCK) LIMITED (CONTINUED)


Other information


The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' Report thereon. The directors are responsible for the other information contained within the Annual ReportOur opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.


We have nothing to report in this regard.


Opinion on other matters prescribed by the Companies Act 2006
 

In our opinion, based on the work undertaken in the course of the audit:


the information given in the Strategic Report and the Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
the Strategic Report and the Directors' Report have been prepared in accordance with applicable legal requirements.


Matters on which we are required to report by exception
 

In the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Directors' Report.


We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:


adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.


Responsibilities of directors
 

As explained more fully in the Directors' Responsibilities Statement set out on page 3, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.


In preparing the financial statements, the directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Company or to cease operations, or have no realistic alternative but to do so.


Page 6

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF AVERY CARE (CANNOCK) LIMITED (CONTINUED)


Auditors' responsibilities for the audit of the financial statements
 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.


Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, and then design and perform audit procedures responsive to those risks, including obtaining audit evidence that is sufficient and appropriate to provide a basis for our opinion. 
In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, we have:
•      considered the nature of the industry and sectors, control environment and business performance;
•      made enquires of management about their own identification and assessment of the risk of irregularities;
•      performed audit work over the risk of management override of controls, including testing of journal entries 
       and other adjustments for appropriateness, evaluating the business rationale of significant transactions 
       outside the normal course of business and reviewing accounting estimates for bias;
•      identified and evaluated compliance with relevant laws and regulations and made enquiries of any 
       instances of non-compliance. The key laws and regulations we considered in this context included UK 
       Companies Act, data protection, anti-bribery, employment law, health and safety, tax legislation, Money 
       Laundering Act and Care Quality Commission (CQC) regulations.
•      discussed matters among the audit engagement team regarding how and where fraud might occur in the 
       financial statements and potential indicators of fraud.
To address the risk of fraud through management bias and override of controls, we:
•      performed analytical procedures to identify any unusual or unexpected relationships.
•      assessed the risk of management override of controls, including through testing journal entries for 
       appropriateness and review of large and unusual bank transactions.
In response to the risk of irregularities and non compliance with laws and regulations, we designed procedures
which included, but are not limited to;
•      agreeing financial statements disclosures to underlying supporting documentation.
•      reviewing minutes of meetings held by those charged with governance.
•      enquiring of management as to actual and potential litigation and claims.
•      reviewing correspondence with HMRC.
•      inspection of regulatory documentation for compliance with CQC requirements and making enquiries with 
       management regarding communication with CQC.


Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance.
Page 7

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF AVERY CARE (CANNOCK) LIMITED (CONTINUED)


The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.


A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditors' Report.


Use of our report
 

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditors' Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.





Alexander Chrysaphiades FCA (Senior Statutory Auditor)
for and on behalf of
Adler Shine LLP
Chartered Accountants
Statutory Auditor
Aston House
Cornwall Avenue
London
N3 1LF

19 December 2025
Page 8

 
AVERY CARE (CANNOCK) LIMITED
 
 
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2025

2025
2024
£
£

Administrative expenses
(889)
(607)

Operating loss
(889)
(607)

Tax on loss
(253,722)
617,868

(Loss)/profit for the financial year
(254,611)
617,261

There were no recognised gains and losses for 2025 or 2024 other than those included in the statement of comprehensive income.

There was no other comprehensive income for 2025 (2024:£NIL).

The notes on pages 12 to 22 form part of these financial statements.

Page 9

 
AVERY CARE (CANNOCK) LIMITED
REGISTERED NUMBER: 09214706

BALANCE SHEET
AS AT 31 MARCH 2025

2025
2024
Note
£
£

Fixed assets
  

Investments
 7 
16,628,910
16,628,910

  
16,628,910
16,628,910

Current assets
  

Debtors: amounts falling due within one year
 8 
13,825,935
14,079,339

Cash at bank and in hand
 9 
32,664
188,828

  
13,858,599
14,268,167

Creditors: amounts falling due within one year
 10 
(34,639,668)
(14,794,625)

Net current liabilities
  
 
 
(20,781,069)
 
 
(526,458)

Total assets less current liabilities
  
(4,152,159)
16,102,452

Creditors: amounts falling due after more than one year
 11 
-
(20,000,000)

  

Net liabilities
  
(4,152,159)
(3,897,548)


Capital and reserves
  

Called up share capital 
 14 
100
100

Profit and loss account
 15 
(4,152,259)
(3,897,648)

  
(4,152,159)
(3,897,548)


The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 


................................................
S B Olsson
Director

Date: 19 December 2025

The notes on pages 12 to 22 form part of these financial statements.

Page 10

 
AVERY CARE (CANNOCK) LIMITED
 

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025


Called up share capital
Profit and loss account
Total equity

£
£
£


At 1 April 2023
100
(4,514,909)
(4,514,809)


Comprehensive income for the year

Profit for the year
-
617,261
617,261



At 1 April 2024
100
(3,897,648)
(3,897,548)



Loss for the year
-
(254,611)
(254,611)


At 31 March 2025
100
(4,152,259)
(4,152,159)


The notes on pages 12 to 22 form part of these financial statements.

Page 11

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.


General information

Avery Care (Cannock) Limited is a private company limited by shares incorporated in England & Wales The registered office address is 3 Cygnet Drive, Swan Valley, Northampton, United Kingdom, NN4 9BS. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the Company's accounting policies (see note 3).

The financial statements are prepared in Pounds sterling, which is the functional currency of the Company, rounded to the nearest £1.

The following principal accounting policies have been applied:

 
2.2

Financial Reporting Standard 102 - reduced disclosure exemptions

The Company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland":
the requirements of Section 7 Statement of Cash Flows;
the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d);
the requirements of Section 11 Financial Instruments paragraphs 11.42, 11.44 to 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);
the requirements of Section 12 Other Financial Instruments paragraphs 12.26 to 12.27, 12.29(a), 12.29(b) and 12.29A;
the requirements of Section 33 Related Party Disclosures paragraph 33.7.

This information is included in the consolidated financial statements of Avery Healthcare Holdings Limited as at 31 March 2025 and these financial statements may be obtained from Companies House.

 
2.3

Exemption from preparing consolidated financial statements

The Company is a parent company that is also a subsidiary included in the consolidated financial statements of a larger group by a parent undertaking established under the law of any part of the United Kingdom and is therefore exempt from the requirement to prepare consolidated financial statements under section 400 of the Companies Act 2006.

Page 12

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.4

Going concern

At the time of approving the financial statements, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
The group headed by Avery Healthcare Holdings Limited has agreed to continue to provide the Company with the necessary financial support and working capital for at least one year from the date of the approval of these financial statements to allow the Company to meet its liabilities as they fall due. The Company is also subject to cross guaranteed property leasing with other group undertakings. Detailed information regarding the financial position of the Group headed by Avery Healthcare Holdings Limited, its cash flows, liquidity position and borrowing facilities are included in the financial statements of Avery Healthcare Holdings Limited, which can be obtained from Companies House.
The Group meets its day-to-day working capital requirements through operating cash flows and debt
financing. Having reviewed the groups financial forecasts and expected future cash flows, the directors are confident that the group has adequate resources to continue in operational existence for the foreseeable future. Consequently, the directors are confident that the group will have sufficient funds to continue to meet its liabilities as they fall due for at least 12 months from the date of approval of the financial statements and therefore have prepared the financial statements on a going concern basis.

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

Page 13

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.7

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.8

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

 
2.9

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.10

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.11

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 14

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)

 
2.12

Provisions for liabilities

Provisions are recognised when an event has taken place that gives rise to a legal or constructive obligation, a transfer of economic benefits is probable and a reliable estimate can be made.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
 
Increases in provisions are generally charged as an expense to profit or loss.

 
2.13

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the Company's Balance Sheet when the Company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Impairment of financial assets

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.
 

Page 15

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.Accounting policies (continued)


2.13
Financial instruments (continued)

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.


3.


Judgements in applying accounting policies and key sources of estimation uncertainty

In the application of the Company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
 
Page 16

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

3.Judgements in applying accounting policies (continued)

The key assumptions and other key sources of uncertainty that have a significant effect of the amounts recognised in the financial statements are described below: 
Recoverability and valuation of investments
Judgements have been made in relation to the recoverability and carrying value of investments. The directors consider the carrying value of investments and whether any impairment is required, or reversal of previously recognised impairments. 
The directors have concluded that the investments values are appropriate and are satisfied that assets are fairly stated at the balance sheet date. 
Provisions
The directors have considered the requirement for provisions in respect of the recoverability of the value of assets and debts, as well as provisions for liabilities (including accrued expenses) based on reasonable expectations, knowledge of the business and historic trends.
Judgements have been made in relation to the recoverability of debtors and the directors are satisfied that adequate provision is made such that debts stated net of provisions are recoverable.
The directors have considered and concluded that the valuations of provisions are appropriate.


4.


Auditors' remuneration

The company has taken advantage of the exemption not to disclose amounts paid for non-audit services as these are disclosed in the consolidated accounts of the parent company.


5.


Employees




The Company did not have any employees during the current or the preceding financial year. 

Page 17

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

6.


Taxation


2025
2024
£
£

Corporation tax


Adjustments in respect of previous periods
142,864
-

Total current tax
142,864
-

Deferred tax


Origination and reversal of timing differences
110,858
(617,868)

Total deferred tax
110,858
(617,868)


Tax on loss
253,722
(617,868)

Factors affecting tax charge for the year

The tax assessed for the year is higher than (2024 - lower than) the standard rate of corporation tax in the UK of 25% (2024 - 25%). The differences are explained below:

2025
2024
£
£


Loss on ordinary activities before tax
(889)
(607)


Loss on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2024 - 25%)
(222)
(152)

Effects of:


Utilisation of tax losses
-
(617,868)

Adjustments to tax charge in respect of prior periods
253,722
-

Group relief
222
152

Total tax charge for the year
253,722
(617,868)

Page 18

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

7.


Fixed asset investments





Investments in subsidiary companies

£



Cost or valuation


At 1 April 2024
16,628,910



At 31 March 2025
16,628,910





Subsidiary undertakings


The following were subsidiary undertakings of the Company:

Name

Registered office

Class of shares

Holding

Avery Homes (Cannock)  Limited
England & Wales
Ordinary
100%
Avery Cannock Opco Limited
England & Wales
Ordinary
100%

Page 19

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

8.


Debtors

2025
2024
£
£


Amounts owed by group undertakings
13,318,925
13,318,607

Other debtors
-
142,864

Deferred taxation
507,010
617,868

13,825,935
14,079,339


Amounts owed by group undertakings are unsecured, interest free, have no fixed date of repayment and are repayable on demand.


9.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
32,664
188,828

32,664
188,828



10.


Creditors: Amounts falling due within one year

2025
2024
£
£

Other loans
20,000,000
-

Trade creditors
175,059
211,223

Amounts owed to group undertakings
14,464,609
14,583,402

34,639,668
14,794,625


Amounts owed to group undertakings are unsecured, interest free, have no fixed date of repayment and are repayable on demand.


11.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Other loans
-
20,000,000

-
20,000,000


Page 20

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

12.


Loans


Analysis of the maturity of loans is given below:


2025
2024
£
£

Other loans
20,000,000
-


20,000,000
-

Amounts falling due 1-2 years

Other loans
-
20,000,000

-
20,000,000


The long-term loans are secured on the Group’s freehold properties and their operating care homes which it is funding.
As at 31 March 2025, the loan was a term loan facility of £20m with connected party. Interest calculated is based on the bank of England base rate with a margin of 5.5%, subject to a cap of 10% in it's first year and a floor of 8% annually, and after the first year the cap is removed. The debt is repayable as a bullet payment in March 2026.


13.


Deferred taxation




2025
2024


£

£






At beginning of year
617,868
-


Charged to profit or loss
(110,858)
617,868



At end of year
507,010
617,868

The deferred tax asset is made up as follows:

2025
2024
£
£


Tax losses carried forward
507,010
617,868

507,010
617,868

Page 21

 
AVERY CARE (CANNOCK) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

14.


Share capital

2025
2024 (restated)
£
£
Allotted, called up and fully paid



1,000 (2024 - 1,000) Ordinary shares of £0.10 each
100
100



15.


Reserves

Profit and loss account

The profit and loss account represents cumulative net gains and losses less distributions made.


16.


Related party transactions

At the balance sheet date, the Company owed £20,000,000 (2024 - £20,000,000) to a company under common control.
The company has taken the exemption available in FRS 102 whereby it has not disclosed transactions with any wholly owned subsidiary undertakings of the group and the wider group.


17.


Controlling party

At the year end, the Company was a subsidiary undertaking of Avery Holdco Cannock Limited, a company incorporated in England and Wales. 
 
The largest UK group in which the results of the Company were consolidated were the group accounts of Veilchenblau Estates Limited, the Company’s ultimate UK parent company. The smallest group in which the results of the Company were consolidated were the group accounts of Avery Healthcare Holdings Limited, a company registered in England and Wales. The consolidated financial statements of both companies can be obtained from Companies House.
 
The ultimate parent company is Siena Enterprises Group Ltd, a company registered in the British Virgin Islands. 
The registered address of Avery Healthcare Holdings Limited is 3 Cygnet Drive, Swan Valley, Northampton, NN4 9BS.
The registered address for Veilchenblau Estates Ltd is Millbank Tower, 21-24 Millbank, London SW1P 4QP.
The registered address for Siena Enterprises Group Ltd is 2nd Floor O'Neal Marketing Associates Building, PO Box 3174, Wickham's Cay II, Road Town, Tortola, British Virgin Islands.

 
Page 22